Celltech Chiroscience Acquisition Of Medeva Provides Marketing Muscle
Executive Summary
Medeva will bring a sales force of 400 reps, including 180 reps in the U.S., to the proposed merger with Celltech Chiroscience.
You may also be interested in...
The Liposome Company Moves Past Evacet Set-Backs With Elan Merger
Elan would add a 40 rep oncology sales force to market its non-opioid analgesic ziconotide with the acquisition of The Liposome Company announced March 6.
The Liposome Company Moves Past Evacet Set-Backs With Elan Merger
Elan would add a 40 rep oncology sales force to market its non-opioid analgesic ziconotide with the acquisition of The Liposome Company announced March 6.
Medeva Fluvirin Production Returns To Market-Demand Level
Production of Medeva's influenza vaccine Fluvirin has returned to levels of market demand following improvements in the manufacturing process, the company said.